Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
An Illinois federal judge has denied GlaxoSmithKline’s request for a new trial in a case involving the suicide of a law firm partner who ingested Paxil for a week before his death, finding the $3 million wrongful death verdict was supported by the evidence.
Cordis Corp. has asked the U.S. Supreme Court to review a federal appeals court’s holding that plaintiffs’ request for consolidation of eight IVC filter actions does not constitute a request for a joint trial under the Class Action Fairness Act.
DePuy Orthopaedics Inc. and Johnson & Johnson have asked a federal appeals court to reconsider its restatement of claims accusing them of palming off latently defective versions of its Pinnacle hip replacement device on unsuspecting doctors who sought government reimbursement for the devices.
The Missouri Supreme Court has upheld a $38 million verdict to a woman who alleged her spina bifida was caused by her in utero exposure to Depakote, ruling that the evidence supported the jury’s finding that Abbott Laboratories Inc. failed to adequately warn of the antiepileptic drug’s risks.
An Arizona federal judge has refused to grant class certification to plaintiffs who received C.R. Bard inferior vena cava filters and are seeking medical monitoring, finding the claims fail to satisfy Rule 23(b) requirements because the relief sought is monetary, not injunctive.
Product Liability Claims in Wash. Federal Surgical Stapler Case Dismissed; Privacy Claims to Proceed
A Washington federal judge has awarded Ethicon Endo-Surgery Inc. summary judgment on product liability claims in a surgical stapler action, finding the plaintiff failed to proffer credible evidence that the stapler malfunctioned during her surgery.
An Indiana federal judge has allowed failure-to-warn and design defect claims to proceed against Boehringer Ingelheim in a Jardiance action, finding they are not preempted because Boehringer did not show that the FDA would have rejected any proposed changes to the label.
An Illinois federal jury has awarded the plaintiff in an Ethicon Gynecare TVT Obturator System action $55,000 in compensatory damages after determining that Ethicon and Johnson & Johnson negligently misrepresented the device’s safety.
A jury in Pennsylvania awarded $57.1 million to a woman who alleged she was injured by Ethicon’s TVT-Secur sling and TVT pelvic mesh devices, after determining that the products were defectively designed.
New York federal judge has awarded Janssen Pharmaceuticals Inc. summary judgment in a Risperdal gynecomastia case, finding the plaintiff failed to show that his doctor would not have prescribed the drug had the warnings been more extensive.